CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 


Moderna Inc 's EBITDA Margin by quarter

Trends, Rankings, Statistics



MRNA EBITDA Margin (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Revenue Change 3046.73 % 6462.07 % 22989.76 % 431893.13 % 309527.45 %
Seq. Revenue Change 14.12 % 124.78 % 239.38 % 261.44 % 137.99 %
Revenue In Millions $4,969.00 $4,354.00 $1,937.00 $570.75 $157.91
EBITDA Margin 72.89 % 71.93 % 65.83 % - -
EBITDA Margin Total Ranking # 319 # 303 # 328 # #
EBITDA In Millions $3,622.00 $3,132.00 $1,275.08 $-263.31 $-224.16
Y / Y EBITDA Change - - - - -
Seq. EBITDA Change 15.64 % 145.63 % - - -


Commenting Third Quarter 2021 EBITDA Margin
Moderna Inc EBITDA grew by 15.64 % in III. Quarter sequntially to 3,622 millions, while Revenue increased by 14.12 %, this led to improvement in Company's EBITDA Margin to 72.89 %, EBITDA Margin remained below Moderna Inc average.

Observing third quarter 2021 results within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher EBITDA Margin. While EBITDA Margin overall ranking has deteriorated compare to previous quarter from 303 to 319.
Learn about Operating Margin
MRNA's EBITDA Margin third quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 11
Healthcare Sector # 34
Overall # 319

EBITDA Margin Statistics
High Average Low
961.25 % 327.36 % 65.83 %
(Sep 30 2015)   (Mar 31 2021)




Other EBITDA Margin Profitability Ratios
MRNA's Cumulative EBITDA Margin
Biotechnology & Pharmaceuticals Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
MRNA's EBITDA Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for MRNA's Competitors
EBITDA Margin Profit Margin for Moderna Inc 's Suppliers
EBITDA Margin Profit Margin for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's EBITDA Growth
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Sep 30 2021, within Biotechnology & Pharmaceuticals Industry EBITDA MarginSep 30 2021 MRQ EBITDASep 30 2021 MRQ Revenue
American Bio Medica Corporation  118.73 %$ 0.729 $ 0.614 
Vir Biotechnology Inc   108.33 %$ 112.248 $ 103.616 
Agenus Inc  77.30 %$ 195.539 $ 252.954 
Moderna Inc   72.89 %$ 3,622.000 $ 4,969.000 
Fulgent Genetics Inc   71.29 %$ 162.446 $ 227.868 
Iteos Therapeutics Inc   69.62 %$ 72.589 $ 104.271 
Halozyme Therapeutics Inc   66.98 %$ 77.579 $ 115.830 
Gilead Sciences Inc   56.74 %$ 4,211.000 $ 7,421.000 
Royalty Pharma Plc  45.43 %$ 266.123 $ 585.773 
Abbvie Inc   44.62 %$ 6,400.000 $ 14,342.000 
Iterum Therapeutics Plc  40.62 %$ 3.974 $ 9.783 
Bio techne Corp  35.74 %$ 92.117 $ 257.719 
Repligen Corp  32.19 %$ 57.364 $ 178.216 
Avantor Inc   18.79 %$ 344.700 $ 1,834.300 
Cyanotech Corp  15.87 %$ 1.495 $ 9.419 
Biogen Inc   15.27 %$ 424.300 $ 2,778.900 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

YORW's Profile

Stock Price

YORW's Financials

Business Description

Fundamentals

Charts & Quotes

YORW's News

Suppliers

YORW's Competitors

Customers & Markets

Economic Indicators

YORW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071